Quality of life after esophagectomy and endoscopic therapy for Barrett's esophagus with dysplasia

Diseases of the Esophagus

Volumn 23, Issue 6, 2010, Pages 458-464

  Schembre, D ^a   Arai, A ^a   Levy, S ^a   Farrell Ross, M ^a   Low, D ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

Barrett's esophagus; Endoscopic mucosal resection; Esophageal cancer; Esophagectomy; Photodynamic therapy; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; DYSPLASIA; ENDOSCOPIC THERAPY; ESOPHAGUS RESECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SHORT FORM 36;

AGED; BARRETT ESOPHAGUS; ESOPHAGECTOMY; ESOPHAGOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 77955967026     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.01042.x     Document Type: Article

References (38)

1. http://www.cancer.gov, National Cancer Institute, Available at: (accessed December 2, 2006
2. Overholt B F, Lightdale C J, Wang K K. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 2005, 62:488-98.
3. Fleischer D E, Overholt B F, Sharma V K. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 2008, 68:867-76.
4. Johnston M H. Cryotherapy and other newer techniques. Gastrointest Endosc Clin N Am 2003, 13:491-504.
5. Buttar N S, Wang K K, Lutzke L S. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc 2001, 54:682-8.
6. Schembre D B, Huang J L, Lin O S. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Gastrointest Endosc 2008, 67:595-601.
7. Prasad G A, Wang K K, Buttar N S. Long-term survival following endoscopic and surgical treatment of high-grade dyslasia in Barrett's esophagus. Gastroenterol 2007, 132:1226-33.
8. Ganz R A, Overholt B F, Sharma V K. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. multicenter registry. Gastrointest Endosc 2008, 68:35-40.
9. Prasad G A, Wu T T, Wigle D A. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterol 2009, 137:815-23.
10. Shaheen N J, Sharma P, Overholt B F. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009, 360:2277-88.
11. May A, Gossner L, Pech O. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy 2002, 34:604-10.
12. Deschamps C, Nichols F C, Cassivi S D. Long-term function and quality of life after esophageal resection for cancer and Barrett's. Surg Clin N Am 2005, 85:649-56.
13. Franchimont D, Covas A, Brasseur C. Newly developed Barrett's esophagus after subtotal esophagectomy. Endoscopy 2003, 35:850-3.
14. Ware J E, Sherbourne C D. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection. Med Care 1992, 30:473-83.
15. Hemingway H, Stafford M, Stansfeld S. Is the SF-36 a valid measure of change in population health? Results from the Whitehall II study. Br Med J 1997, 315:1273-9.
16. Eypasch E, Wiliams J I, Wood-Dauphinee S. Gastrointestinal quality of life index: development, validation and application of a new instrument. Br J Surg 1995, 82:216-22.
17. Decker G, Borie F, Bouamrirene D. Gastrointestinal quality of life before and after laparoscopic Heller myotomy with partial posterior fundoplication. Ann Surg 2002, 6:750-8.
18. Nieveen Van Kijkum E J, Terwee C B, Oosterveld P. Validation of the gastrointestinal quality of life index for patients with potentially operable periampulary carcinoma. Br J Surg 2000, 87:110-5.
19. Sailer M, Bussen D, Debus E S. Quality of life in patients with benign anorectal disorders. Br J Surg 1998, 85:1716-9.
20. Bulent Mentes B, Akin M, Irkrucu O. Gastrointestinal quality of life in patients with symptomatic or asymptomatic cholelithiasis before and after laparoscopic cholecystectomy. Surg Endosc 2001, 15:1267-72.
21. Kamolz T, Granderath F, Pointner R. Laparoscopic antireflux surgery: disease-related quality of life assessment before and after surgery in GERD patients with and without Barrett's esophagus. Surg Endosc 2003, 17:880-5.
22. Devesa S S, Blot W J, Fraumeni J F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998, 83:2049-53.
23. Birkmeyer J D, Siewers A E, Finlayson E V A. Hospital volume and surgical mortality in the United States. N Eng J Med 2002, 346:1128-37.
24. Headrick J R, Nichols F C, Miller D L. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thoracic Surg 2003, 73:1697-703.
25. Havelund T, Lind T, Wiklund I. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol 1999, 94:1782-9.
26. Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 2004, 22:108-14.
27. Young M M, Deschamps C, Allen M S. Esophageal reconstruction for benign disease: self-assessment of functional outcome and quality of life. Ann Thorac Surg 2000, 70:1799-802.
28. Baba M, Aikou T, Natsugoe S. Appraisal of ten-year survival following esophagectomy for carcinoma of the esophagus with emphasis on quality of life. World J Surg 1997, 21:282-5.
29. Tabira Y, Yasunaga M, Nagamoto N. Quality of life after esophagectomy for cancer: an assent using the questionnaire with the face scale. Surg Today 2002, 32:213-9.
30. Chang L C, Oelschlager B K, Quiroga E. Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus. J Gastrointest Surg 2006, 10:341-6.
31. Moraca R J, Low D E. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg 2006, 141:545-51.
32. Sampliner R E. Endoscopic ablative therapy for Barrett's esophagus: current status. Gastrointest Endosc 2004, 59:66-9.
33. Eloubeidi M A, Provenzale D. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus. Am J Gastroenterol 2000, 95:1881-7.
34. Fisher D, Jeffreys A, Bosworth H. Quality of life in patients with Barrett's esophagus undergoing surveillance. Am J Gastroenterol 2002, 97:2193-200.
35. Gerson L B, Ullah N, Hastie T. Does cancer risk affect health-related quality of life in patients with Barrett's esophagus? Gastrointest Endosc 2007, 65:16-25.
36. Dow K H, Ferrell B R, Leigh B R. An evaluation of the quality of life among long-term survivors of breast cancer. Breast Ca Res Treat 1996, 39:261-73.
37. Schembre D. Endotherapy for Barrett's esophagus with high-grade dysplasia and intramucosal carcinoma. J Gastrointest Surg 2009, 13:1172-8.
38. Viklund P, Lindblad M, Lagergren J. Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection. World J Surg 2005, 29:841-8.